Gandalusao, Nestor D.
HRN: 28-56-47 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2026
CO-AMOXICLAV 625MG (TAB)
02/14/2026
02/21/2026
PO
625mg
BID
Lacerated Wound
Checking Initial Appropriateness